Bionano Genomics (BNGO) vs Milestone Scientific (MLSS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Milestone Scientific (MLSS) has outperformed Bionano Genomics (BNGO) over the past year, losing 23.4% versus a loss of 26.3%. Over five years, MLSS leads with a -82.9% price change compared with -100.0% for BNGO. Milestone Scientific is the larger company by market cap ($32.6 million vs $17.2 million), about 1.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BNGO | MLSS |
|---|---|---|
| Share price | $1.46 | $0.36 |
| Market cap | $17.19M | $32.62M |
| 1-day change | 0.00% | -2.70% |
| YTD return | -4.58% | +33.33% |
| 1-year return | -26.26% | -23.40% |
| 5-year return | -99.95% | -82.94% |
| EPS (TTM) | $-3.02 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.23 | $0.58 |
| 52-week low | $1.00 | $0.22 |
| Distance from 52-week high | -34.53% | -37.93% |
| Analyst consensus | none | none |
| Avg. price target upside | +242.47% | +247.22% |
| Average volume | 921.59K | 128.06K |
| Shares outstanding | 11.78M | 90.61M |
| Employees | 95 | 15 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Bionano Genomics
BNGO stock →Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.
Healthcare · Medical Instruments & Supplies · 95 employees
About Milestone Scientific
MLSS stock →Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments.
Healthcare · Medical Instruments & Supplies · 15 employees
BNGO vs MLSS FAQ
Which is bigger, Bionano Genomics or Milestone Scientific?
Milestone Scientific (MLSS) is larger, with a market capitalization of $32.62M compared with $17.19M for Bionano Genomics (BNGO).
Which stock has performed better over the past year, BNGO or MLSS?
MLSS returned -23.40% over the past 12 months, compared with -26.26% for BNGO (price return, excluding dividends). Past performance does not predict future results.
Are Bionano Genomics and Milestone Scientific in the same industry?
Yes. Both are classified in the Medical Instruments & Supplies industry within the Healthcare sector.